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The regulation of human immunodeficiency virus type 1infection and replication in primary monocytes was
investigated by mutagenesis of recombinant proviral clones containing an env determinant required for the
infectivity of monocytes. Virus replication was assayed by determination of reverse transcriptase activity in
culture fluids and by recovery of virus from monocytes following cocultivation with uninfected peripheral blood
mononuclear cells. Three virus replication phenotypes were observed in monocytes: productive infection, silent
infection, and no infection. Incorporation of the monocytetropic env determinant in a full-length clone
incapable of infection or replication in primary monocytes (no infection) conferred the capacity for highly
efficient virus replication in monocytes (productive infection). Clones with the env determinant but lacking
either functional vpr or vpu genes generated lower replication levels in monocytes. Mutation of both vpr and
vpu, however, resulted in nearly complete attenuation of virus replication in monocytes, despite subsequent
virus recovery from infected monocytes by cocultivation with uninfected peripheral blood mononuclear cells
(silent infection). These findings indicate a central role for the "accessory" genes vpu and vpr in productive
human immunodeficiency virus type 1 replication in monocytes and indicate that vpu and vpr may be capable
of functional complementation.
Human immunodeficiency virus type 1 (HIV-1) infection
of macrophages has been demonstrated in brain, spinal cord,
lung, lymph node, and skin during subclinical infection and
disease and is postulated to underlie important clinical
manifestations of HIV-1 infection, including disease latency
and development of a spectrum of AIDS-related central
nervous system disorders (2, 4, 11, 14, 15, 19, 33, 37).
However, detailed molecular analysis of virus-host cell
interactions involving monocytes was limited until recently
by the restricted tropism of the earliest and most widely
studied HIV-1 genetic clones for primary monocytes cultured in vitro (14, 15). Previously, we and others have
demonstrated that a discrete env determinant, including the
V3 loop but not the CD4-binding domain, is necessary and
sufficient for HIV-1 infection of monocytes (23, 29, 36).
Additionally, we have identified three virus replication phenotypes in monocytes in vitro, using molecularly defined
proviral clones (35). These include productive infection,
with the generation of high virus replication levels; silent
infection, with low to undetectable virus replication in
monocytes, despite ultimate virus recovery from infected
monocytes following cocultivation with uninfected, phytohemagglutinin-stimulated peripheral blood mononuclear
cells (PBMCs [lymphoblasts]); and no infection, with neither
virus replication in nor virus recovery from monocytes
observed. In the present study, we investigated the roles of
the HIV-1 "accessory" genes vpr and vpu, which are
dispensable for virus replication in primary and immortalized CD4+ T lymphocytes. We demonstrate that vpr and vpu
are central to the regulation of virus replication in primary
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monocytes and together mediate the expression of silent
versus productive infection.
To study viral regulation of monocyte infection, we utilized a panel of chimeric HIV-1 clones, constructed from the
nonmonocytetropic clone HXB2 and the monocytetropic
clone ADA, as previously described (16, 26, 35, 36). To
correct a vpr defect in each of these clones, the result of a
single base insertion in HXB2, 2.7-kb SalI-BamHI HXADA
DNA fragments (nucleotides 5785 to 8474) were subcloned
into the full-length proviral clone NL4-3, in which the vpr
open reading frame is intact (1). The resultant NLHXADA
clones contained the ADA-derived env determinant previously localized to nucleotides 7040 to 7323, flanked by
additional ADA- or HXB2-derived sequences encoding
other portions of env and vpu and small portions of tat and
rev. A clone in which the entire 5785-to-8474 sequence was
HXB2 derived (thus lacking a monocytetropic env determinant) was used as a negative control for these experiments.
Because HXB2 lacks a vpu initiator methionine codon,
clones in which vpu was HXB2 derived were defective for
that product, in contrast to clones with an ADA-encoded
vpu. Finally, a vpr mutant corresponding to each NLHXADA clone was generated by introducing a frameshift mutation at codon 63.
Virions from the recombinant clones, generated by transfection, were assayed for their ability to infect and replicate
in primary monocytes by the presence of reverse transcriptase (RT) activity in culture supernatants (25) and by
the ultimate recovery of virus following cocultivation of
monocytes with uninfected PBMCs. The results are summarized in Fig. 1. All clones containing the ADA-derived env
determinants and an intact vpr gene generated high virus
replication levels in monocytes. Inactivation of vpr in these
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FIG. 1. Replication of recombinant HIV-1 clones with both wild-type and mutant vpr genes. (A) The panel of recombinant NLHXADA
clones is represented diagrammatically. The region of the genome corresponding to the HXADA fragments (nucleotides 5785 to 8474) is
expanded to highlight the relative positions of HXBZ- and ADA-derived sequences. The open reading frames in this portion of the genome
are represented above. Recombinant clones were generated by reciprocal DNA fragment exchanges of ADA- and HXB2-derived sequences
into a SalI-BnrnHI fragment (5785 to 8474) from HXB2 subcloned into an intermediate shuttle vector, utilizing the restriction enzyme
sites indicated on top. The resultant chimeric SalI-BamHI fragments were then subcloned into the clone NL4-3 to generate
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clones, however, generated divergent results, depending
upon the derivation of nucleotide sequences 5999 to 6345
(SK fragment). Clones in which this portion of the genome
was ADA derived generated lower (but readily detectable)
virus replication levels than did their wild-type vpr counterparts. However, vpr mutants in which S K was HXB2
derived typically failed to generate virus replication levels
detectable above background in monocytes, despite subsequent virus recovery from these cultures onto uninfected
PBMCs. The negative control clone, which carried a wildtype vpr but lacked the monocytetropic env determinant,
generated virions which neither replicated in nor were
recovered from monocytes, as previously demonstrated. No
significant differences were seen in the replication of each
virus strain on PBMCs obtained from several different
donors.
Monocytes were infected with recombinant HIV-1 clones
containing a functional vpr gene, stained with toluidine blue,
and examimed by light microscopy (1-km-thick plastic sections). Cultures infected with a nonmonocytetropic virus,
NLHXADA-SK, which contains a functional vpu gene, were
indistinguishable from uninfected cells, with rare, small
multinucleated cells (Fig. 2A). Cultures productively infected with virus containing the monocytetropic env determinant and a functional (NLHXADA-SM [Fig. 2B]) or
nonfunctional (NLHXADA-GG [Fig. 2C]) vpu gene showed
characteristic cytopathic effects (15). These consisted of the
formation of multinucleated giant cells, often containing 10
or more nuclei per cell, and cell lysis. The frequencies and
sizes of these cells were comparable in the NLHXADASM- and NLHXADA-GG-infected monocyte cultures. Virus
production and cellular degeneration and necrosis were
primarily confined to the multinucleated cells. Transmission
electron microscopy examination demonstrated typical budding and mature virions in intracellular vacuoles that were
associated with the plasma membrane, in both the presence
and absence of vpu, but not in the NLHXADA-SK-infected
cells (Fig. 2D). Freeze fracture scanning electron microscopy demonstrated budding of virion particles from the
plasma membrane of monocytes infected with virus which
lacked a functional vpu (Fig. 2E). No virus could be detected
in monocytes infected with recombinant clones lacking both
vpr and vpu (data not shown).
The S K fragment encodes the entire vpu gene product, 14
amino acids at the C termini of both the tat and the rev first
exons, and the N-terminal 41 amino acids of env (Fig. 3).
Although the absence of a vpu initiator methionine codon in
HXB2 is the most obvious difference between the SK
portions of HXB2 and ADA, a role for tat, rev, or env could
not be ruled out. The env sequences differ at 7 of 41
predicted amino acid positions, not including the nonaligned
insertion of 3 residues and deletion of 4 residues in ADA. All
but three of these differences are confined to the signal
peptide, which varies by up to 30% between different clones

NOTES

3927

(20). Furthermore, tat and rev both differ at 3 of 14 amino
acid positions between the ADA and HXB2 SK fragments,
with four of these six changes being conservative in nature.
Therefore, it is unlikely that these alterations in env, tat, or
rev alter their function. However, to formally determine the
specific requirement for vpu during HIV-1 infection of monocytes, the vpu initiator methionine codon of the silent
infection clone NLHXADA-GG (vpr mutant) was restored
by site-directed mutagenesis. The resultant clone was found
to generate virus capable of productive infection of monocytes (data not shown).
HIV-1 and related lentiviruses are distinct from most other
retroviruses in that besides the structural g a g , pol, and env
genes common to all retroviruses, they also encode a number of genes whose functions have been shown or are
speculated to be regulatory in nature. In HIV-1, these genes
include tat, rev, vif, nef, vpu, and vpr (6-8, 26, 32, 38). While
tat, rev, and vif are essential for viral gene expression or
virion infectivity, the precise role and overall importance of
vpr, vpu, and nef are unclear, since these genes are dispensable for virus infection and replication in CD4+ lymphocytes
in vitro (8-10, 12, 13, 22, 24, 30, 32). The availability of
molecular HIV-1 clones which infect and replicate in monocytes at levels comparable to those observed with many
monocytetropic virus isolates has facilitated investigation of
the role that these viral genes may play in regulating the
virus life cycle in monocytes. In the present study, we
observed moderately decreased levels of virus replication in
the absence of either vpr or vpu, whereas in the absence of
both genes, virus replication in monocytes dropped to levels
barely at or below the level of detection by the RT assay,
such that infection of these cells usually could be detected
only by virus rescue onto PBMCs.
The vpr open reading frame encodes a protein of 96 amino
acids in most HIV-1 clones and is conserved in other
lentiviruses, including visna-maedi virus (20, 31). Previous
studies have shown that vpr is not required for HIV-1
infection or replication in CD4+ lymphocytic cell lines in
vitro, although its inactivation led to slower replication
kinetics and delayed cytopathogenicity in these cells (6, 10,
24). A recent study involving HIV type 2 (HIV-2) has shown
that vpr is likewise dispensable during infection of PBMCs
and T-cell lines but essential for productive infection of
monocytes (17). The vpr protein has been demonstrated by
radioimmunoprecipitation to be virion associated, and thus it
is speculated to function either late in the virus life cycle,
during particle assembly or maturation, or early, during the
initial stages of infection (6). The vpu gene encodes an 80to-82-amino-acid protein. It has not been reported whether
the vpu protein is found in virion particles. vpu has been
shown to augment virion particle release from infected cells
without affecting levels of viral RNA or protein synthesis (8,
32). In the absence of vpu, a higher ratio of immature to
mature particles has been seen, with a shift in capsid

recombinant NLHXADA clones. T o inactivate vpr, clones were digested with EcoRI (nucleotide 5745), treated with Klenow fragment, and
religated t o generate a 4-bp insertion, as previously described (24). The replication levels of these clones in monocytes are summarized to the
right of each clone. Monocytes were infected a s previously described (36) by using filtered virus stocks generated by transfection of proviral
D N A onto SW480 cell monolayers, and titers were determined by measuring RT activity. Infections were done at low multiplicities of
infection (10 t o 100 tissue culture infective doses per well) with monocytes plated at an initial density of 2 x lo5 cells per well. Virus replication
was monitored by serial determinations of R T activity in culture supernatants (25). Peak R T activities (days 26 t o 29) are expressed as lo5
counts per minute per milliliter. T o determine virus rescue, fresh, uninfected PBMCs were added to monocyte cultures at 29 days
postinfection, cocultivated (co-cult) for 2 days, and maintained separately for up to 12 additional days, while RT activity was monitored.
Rescue was scored a s positive with two successive R T results that were more than fivefold above background level. ( B ) The replication
kinetics of representative NLHXADA clones is graphed. Similar results were obtained in three to five replicate experiments.
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FIG. 2. Light, transmission, and freeze fracture scanning electron microscopy of infected monocytes. Light micrographs of toluidine
blue-stained semithin plastic sections showing typical fields of primary monocytes infected by nonmonocytetropic clone NLHXADA-SK (35)
(A) and monocytetropic clones NLHXADA-SM ( B ) and NLHXADA-GG (C) are shown (15). The multinucleated giant cells were fewer and
smaller in panel A than in panels B and C. Magnification, ~ 4 8 0 .Infected adherent cultured cells were carefully washed twice with
phosphate-buffered saline (PBS), fixed in situ with 2% glutaraldehyde ( p H 7.2) in PBS, scraped free with a rubber policeman, transferred to
a 15-ml plastic conical tube, and pelleted for 10 min at 600 x g centrifugation. The cells were mixed with warm agar, repelleted in the
Microfuge for 1 min, and refrigerated overnight to form a firm agar block. The cell block was divided into small pieces and processed into
Spurr's plastic, after osmification and block uranyl acetate staining (15). Sections (1 km thick) were stained with toluidine blue for light
microscopy, while thin sections (600 A [60.0 nm]) were stained with uranyl acetate and lead citrate for transmission electron microscopy. ( D )
Transmission electron micrograph of a small portion of a multinucleated cell from NLHXADA-GG-infected monocytes showing a
cytoplasmic vacuole (lower left) containing immature and mature virions and numerous typical mature particles associated with a stretch of
plasma membrane. Magnification, ~ 3 4 , 0 0 0 .( E ) Transmission electron microscopy view of NLHXADA-GG-infected monocytes, stabilized
by formaldehyde fixation before quick-freezing, freeze-drying, and platinum replication (18). Budding from the convoluted surface are several
50-nm-diameter brightly outlined spherical virus particles. At higher magnification (not shown), these display characteristic surface coats of
gp120 "pegs."

formation from the plasma membrane to intracellular membranes (8). In monocytes, however, particle assembly and
release occur both at the plasma membrane and in intracellular vacuoles in the presence or absence of vpu,as shown in
Fig. 2D.
It is intriguing that HIV-2 and simian immunodeficiency
virus lack a vpu open reading frame but instead carry a gene
designated vpx,which encodes a protein of 114 to 118 amino
acids in these viruses (20). vpu and vpx occupy similar
positions in their respective viral genomes, between pol and
env,but have only distant amino acid homology. Recently, it
has been suggested that vpx and vpr arose by duplication
from a common progenitor in HIV-2 and simian immunodeficiency virus, on the basis of predicted amino acid sequence
homology between the genes (34). T o investigate the possibility of a similar link between vpr and vpu in HIV-1, the
predicted amino acid sequences of both vpu and vpx were
aligned with that of vpr (Fig. 4). Although less compelling
that the homology between vpr and vpx, a 38% identity was
observed between vpr and vpu over a 24-residue overlap at
the C terminus of vpu and the N terminus of vpr. These
sequences were particularly rich in acidic residues. Similarity in the hydrophilicity profiles of these portions of the vpu,
vpr, and vpx products was also noted. The striking effect on
virus replication levels in monocytes observed only when
both genes were defective suggests that their gene products
may perform similar roles and thus provide partial functional
complementation. Alternatively, since lower replication lev-

els were observed in the absence of either gene, the nearly
complete attenuation observed in the absence of both may
result from a compound effect of the loss of two relatively
important but functionally unrelated genes. More detailed
studies to determine the precise mechanisms of action of the
vpr and \pic gene products will be required to address these
alternatives. In either case, our data indicate that together,
vpr and a second determinant, ~ p u are
, more important for
efficient HIV-1 infection and replication in primary monocytes than was observed previously in lymphocytes. These
observations provide a rationale for designing potential
antiviral therapies to block the action of these gene products
during HIV-1 infection of monocytes.
Persistent infection of tissue macrophages plays an important role in the pathogenic effects of other lentiviruses,
including equine infectious anemia virus, visna-maedi virus,
and caprine arthritis-encephalitis virus, providing a sanctuary for continuous virus replication in the face of a vigorous
host immune response (15, 21). The onset of increased virus
replication has been correlated with the onset of clinical
disease manifestations, such as encephalitis, pneumonitis,
arthritis, and hemolytic anemia. Similarly, HIV-1 infection
of macrophages generates a reservoir of virus which is
present throughout the course of subclinical infection and
clinical disease. The existence of poorly replieative HIV-1
variants may be essential for establishment of persistent
macrophage infection during the early, asymptomatic stage
of disease. Several studies have suggested a relationship
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FIG. 3. Comparison of S K virus replication determinant from HXB2 and ADA. The predicted amino acid sequences o f rplr and the
portions of rat, re\,, and mr3which are encoded by nucleotides 5909 to 6315 ( S K fragment) from HXB2 and ADA are aligned by using
single-letter amino acid designations. Identical residues are indicated within hoxes.
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FIG. 4. Predicted amino acid homology between vpr, vpu, and vpx. The predicted amino acid sequence of the NL4-3-derived vpr gene is
aligned with homologous regions of the ADA-derived vpu gene and the vpx gene encoded by the HIV-2,,? clone, with single-letter amino
acid designations. Identical residues are indicated within boxes. Hydrophilicity profiles for the correspond~ngsegments of each protein are
shown at the bottom.

between the in vitro replicative properties of HIV-1 isolates
in T lymphocytes and clinical-disease stage, with earlier
isolates tending to replicate more slowly and to lower levels
("slow, low") than isolates from later stages of disease
("rapid, high") (3, 5 , 27). Nonessential regulatory genes are
ideally suited to act as "molecular switches" for control of
replication phenotypes by their activation or inactivation,
particularly in viruses such as HIV-1, which characteristically generate high levels of sequence diversity. We demonstrate here that discrete genetic alterations in such accessory
genes result in profoundly different replication rates in
monocytcs in vitro, which suggests a mechanism for transition from subclinical to clinical disease in vivo. These
findings thus provide a rationale for addressing on a wider
scale whether functional status of vpr and/or vpu correlates
with disease stage or serves as a potential prognostic indicator of disease progression and outcome.
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